首页> 外文期刊>Endocrine journal >Significant interaction between RETN -420 G/G genotype and lower BMI on decreased risk of type 2 diabetes mellitus (T2DM) in Japanese — the J-MICC Study [Rapid Communication]
【24h】

Significant interaction between RETN -420 G/G genotype and lower BMI on decreased risk of type 2 diabetes mellitus (T2DM) in Japanese — the J-MICC Study [Rapid Communication]

机译:在日本,RETN -420 G / G基因型与较低的BMI之间的显着相互作用降低了2型糖尿病(T2DM)的风险— J-MICC研究[快速沟通]

获取原文
           

摘要

References(25) Cited-By(1) We examined the association of the RETN (resistin) -420 C>G polymorphism (rs1862513) with risk of diabetes mellitus (DM), considering lifestyle factors, in Japanese. Subjects were participants of J-MICC Study, where 2,651 participants aged 35-69 years provided their blood for genotyping and lifestyle data after informed consent. Odds ratio (OR) of DM for RETN-420 G/G genotype was estimated using unconditional logistic regression model. Statistically significant interaction on risk of DM was observed between RETN-420 G/G genotype and BMIP = 0.046), and when subjects with RETN-420 C/C+C/G and BMI ≥ 25 (n = 69 for DM and 544 for non-DM) were defined as the reference, the adjusted ORs for subjects with RETN-420 G/G genotype and BMI>25 (n = 10 for DM and 111 for non-DM), RETN-420 C/C+C/G and BMIRETN-420 G/G and BMIRETN-420 G/G genotype with lower BMI on the decreased risk of DM, but the direction was opposite to the reported ones in Japanese. We should be careful in interpretation of the present study results because of the limited sample sizes. Further investigation of this association as well as of the actual biological roles of RETN in the genesis of human metabolic disorders including DM will be required.
机译:参考文献(25)被引用者(1)在日语中,考虑了生活方式因素,我们研究了RETN(抵抗素)-420 C> G多态性(rs1862513)与糖尿病(DM)风险的相关性。受试者是J-MICC研究的参与者,其中2651名年龄在35-69岁之间的参与者在知情同意后为其血液提供了基因分型和生活方式数据。使用无条件逻辑回归模型估算了RETN-420 G / G基因型的DM几率(OR)。在RETN-420 G / G基因型和BMIP = 0.046之间,以及在RETN-420 C / C + C / G和BMI≥25的受试者中,DM风险具有统计学意义的交互作用(DM的n = 69和544的544)。定义为参考,针对RETN-420 G / G基因型且BMI> 25(DM为n = 10,非DM为111)的受试者的调整后OR,为RETN-420 C / C + C / B和BMI较低的G和BMIRETN-420 G / G和BMIRETN-420 G / G基因型降低了DM的患病风险,但与日本报道的方向相反。由于样本量有限,我们在解释本研究结果时应格外小心。需要进一步研究这种关联以及RETN在包括DM在内的人类代谢性疾病的发生中的实际生物学作用。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号